Mitotic catastrophe and cell death induced by depletion of centrosomal proteins

Cell Death and Disease

Volumn 4, Issue 4, 2013, Pages

  Kimura, M ^a   Yoshioka, T ^a   Saio, M ^a,b   Banno, Y ^a   Nagaoka, H ^a   Okano, Y ^a,c  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^c GIFU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Caspase; Centrosome; Checkpoint; Mitotic catastrophe; P53

Indexed keywords

AURORA A KINASE; CASPASE 3; CASPASE 9; CELL PROTEIN; GAMMA TUBULIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN P53; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL CYCLE M PHASE; CELL DEATH; CELL STRUCTURE; CENTROSOME; CHROMOSOME; GENE SILENCING; HUMAN; INTERPHASE; MITOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; AUTOANTIGENS; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CENTROSOME; CYTOSKELETAL PROTEINS; HCT116 CELLS; HELA CELLS; HUMANS; INTERPHASE; MICROTUBULE-ASSOCIATED PROTEINS; MITOSIS; MITOTIC SPINDLE APPARATUS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME-LAPSE IMAGING; TUBULIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84876931029     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.108     Document Type: Article

References (57)

1. Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH et al. Tissuespecific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 1989; 3: 1146-1156
2. Nerlov C. C/EBPalpha mutations in acute myeloid leukaemias. Nat Rev Cancer 2004; 4: 394-400
3. Koschmieder S, Halmos B, Levantini E, Tenen DG. Dysregulation of the C/EBPalpha differentiation pathway in human cancer. J Clin Oncol 2009; 27: 619-628
4. Trivedi AK, Pal P, Behre G, Singh SM. Multiple ways of C/EBPalpha inhibition in myeloid leukaemia. Eur J Cancer 2008; 44: 1516-1523
5. Ross SE, Radomska HS, Wu B, Zhang P, Winnay JN, Bajnok L et al. Phosphorylation of C/EBPalpha inhibits granulopoiesis. Mol Cell Biol 2004; 24: 675-686
6. Geletu M, Balkhi MY, Peer Zada AA, Christopeit M, Pulikkan JA, Trivedi AK et al. Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9. Blood 2007; 110: 3301-3309
7. Trivedi AK, Bararia D, Christopeit M, Peerzada AA, Singh SM, Kieser A et al. Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene 2007; 26: 1789-1801
8. Behre G, Singh SM, Liu H, Bortolin LT, Christopeit M, Radomska HS et al. Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248. J Biol Chem 2002; 277: 26293-26299
9. Rosenbauer F, Tenen DG. Transcription factors in myeloid development: Balancing differentiation with transformation. Nat Rev Immunol 2007; 7: 105-117
10. Gombart AF, Hofmann WK, Kawano S, Takeuchi S, Krug U, Kwok SH et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood 2002; 99: 1332-1340
11. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S et al. Dominantnegative mutations of CEBPA, encoding CCAAT/enhancer binding protein-Alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 2001; 27: 263-270
12. Kato N, Kitaura J, Doki N, Komeno Y, Watanabe-Okochi N, Togami K et al. Two types of C/EBPalpha mutations play distinct but collaborative roles in leukemogenesis: Lessons from clinical data and BMT models. Blood 2011; 117: 221-233
13. Westendorf JJ, Yamamoto CM, Lenny N, Downing JR, Selsted ME, Hiebert SW. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-Alpha, inhibits C/EBP-Alphadependent transcription, and blocks granulocytic differentiation. Mol Cell Biol 1998; 18: 322-333
14. Rangatia J, Vangala RK, Singh SM, Peer Zada AA, Elsasser A, Kohlmann A et al. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction. Oncogene 2003; 22: 4760-4764
15. Radomska HS, Basseres DS, Zheng R, Zhang P, Dayaram T, Yamamoto Y et al. Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J Exp Med 2006; 203: 371-381
16. Subramanian L, Benson MD, Iniguez-Lluhi JA. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J Biol Chem 2003; 278: 9134-9141
17. Keeshan K, He Y, Wouters BJ, Shestova O, Xu L, Sai H et al. Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia. Cancer Cell 2006; 10: 401-411
18. Grandinetti KB, Stevens TA, Ha S, Salamone RJ, Walker JR, Zhang J et al. Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPalpha. Oncogene 2011; 30: 3328-3335
19. Bengoechea-Alonso MT, Ericsson J. The ubiquitin ligase Fbxw7 controls adipocyte differentiation by targeting C/EBPalpha for degradation. Proc Natl Acad Sci USA 2010; 107: 11817-11822
20. Huibregtse JM, Scheffner M, Beaudenon S, Howley PM. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci USA 1995; 92: 5249
21. Mishra A, Godavarthi SK, Jana NR. UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27. Neurobiol Dis 2009; 36: 26-34
22. Talis AL, Huibregtse JM, Howley PM. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem 1998; 273: 6439-6445
23. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75: 495-505
24. Louria-Hayon I, Alsheich-Bartok O, Levav-Cohen Y, Silberman I, Berger M, Grossman T et al. E6AP promotes the degradation of the PML tumor suppressor. Cell Death Differ 2009; 16: 1156-1166
25. Lochab S, Pal P, Kanaujiya JK, Tripathi SB, Kapoor I, Bhatt ML et al. Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells. Proteomics 2012; 12: 1363-1377
26. Cheng J, Yu DV, Zhou JH, Shapiro DJ. Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-Induced apoptosis. J Biol Chem 2007; 282: 30535-30543
27. Tavor S, Park DJ, Gery S, Vuong PT, Gombart AF, Koeffler HP. Restoration of C/EBPalpha expression in a BCR-ABL cell line induces terminal granulocytic differentiation. J Biol Chem 2003; 278: 52651-52659
28. Wang X, Scott E, Sawyers CL, Friedman AD. C/EBPalpha bypasses granulocyte colonystimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood 1999; 94: 560-571
29. Keeshan K, Santilli G, Corradini F, Perrotti D, Calabretta B. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation. Blood 2003; 102: 1267-1275
30. Friedman AD, Keefer JR, Kummalue T, Liu H, Wang QF, Cleaves R. Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha. Blood Cells Mol Dis 2003; 31: 338-341
31. Rosmarin AG, Yang Z, Resendes KK. Transcriptional regulation in myelopoiesis: Hematopoietic fate choice, myeloid differentiation, and leukemogenesis. Exp Hematol 2005; 33: 131-143
32. Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C. CEBPA point mutations in hematological malignancies. Leukemia 2005; 19: 329-334
33. Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 2003; 3: 89-101
34. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG. CCAAT/ enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 1998; 18: 4301-4314
35. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 1997; 94: 569-574
36. Lekstrom-Himes JA. The role of C/EBP(epsilon) in the terminal stages of granulocyte differentiation. Stem Cells 2001; 19: 125-133
37. Chakraborty A, Tweardy DJ. Granulocyte colony-stimulating factor activates a 72-kDa isoform of STAT3 in human neutrophils. J Leukoc Biol 1998; 64: 675-680
38. Valtieri M, Santoli D, Caracciolo D, Kreider BL, Altmann SW, Tweardy DJ et al. Establishment and characterization of an undifferentiated human T leukemia cell line which requires granulocyte-macrophage colony stimulatory factor for growth. J Immunol 1987; 138: 4042-4050
39. Guchhait P, Tosi MF, Smith CW, Chakaraborty A. The murine myeloid cell line 32Dcl3 as a model system for studying neutrophil functions. J Immunol Methods 2003; 283: 195-204
40. Bernassola F, Karin M, Ciechanover A, Melino G. The HECT family of E3 ubiquitin ligases: Multiple players in cancer development. Cancer Cell 2008; 14: 10-21
41. Kuhne C, Banks L. E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J Biol Chem 1998; 273: 34302-34309
42. Kumar S, Talis AL, Howley PM. Identification of HHR23A as a substrate for E6-Associated protein-mediated ubiquitination. J Biol Chem 1999; 274: 18785-18792
43. Oda H, Kumar S, Howley PM. Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. Proc Natl Acad Sci USA 1999; 96: 9557-9562
44. Thomas M, Banks L. Inhibition of Bak-Induced apoptosis by HPV-18 E6. Oncogene 1998; 17: 2943-2954
45. Mani A, Oh AS, Bowden ET, Lahusen T, Lorick KL, Weissman AM et al. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Res 2006; 66: 8680-8686
46. Shimoji T, Murakami K, Sugiyama Y, Matsuda M, Inubushi S, Nasu J et al. Identification of annexin A1 as a novel substrate for E6AP-mediated ubiquitylation. J Cell Biochem 2009; 106: 1123-1135
47. Lane MD, Tang QQ, Jiang MS. Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem Biophys Res Commun 1999; 266: 677-683
48. Harris TE, Albrecht JH, Nakanishi M, Darlington GJ. CCAAT/enhancer- binding proteinalpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding. J Biol Chem 2001; 276: 29200-29209
49. Umek RM, Friedman AD, McKnight SL. CCAAT-enhancer binding protein: A component of a differentiation switch. Science 1991; 251: 288-292
50. Yeamans C,Wang D, Paz-Priel I, Torbett BE, Tenen DG, Friedman AD. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. Blood 2007; 110: 3136-3142
51. Porse BT, Bryder D, Theilgaard-Monch K, Hasemann MS, Anderson K, Damgaard I et al. Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. J Exp Med 2005; 202: 85-96
52. Taskesen E, Bullinger L, Corbacioglu A, Sanders MA, Erpelinck CA, Wouters BJ et al. Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: Further evidence for CEBPA double mutant AML as a distinctive disease entity. Blood 2011; 117: 2469-2475
53. Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Zimmermann M, Peeters JK, Valk PJ et al. Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia. Haematologica 2011; 96: 384-392
54. Pulikkan JA, Peramangalam PS, Dengler V, Ho PA, Preudhomme C, Meshinchi S et al. C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood 2010; 116: 5638-5649
55. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ et al. The Angelman syndrome-Associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol 1999; 19: 1182-1189
56. Singh SM, Trivedi AK, Behre G. C/EBPalpha S248A mutation reduces granulocytic differentiation in human leukemic K562 cells. Biochem Biophys Res Commun 2008; 369: 692-694
57. Pal P, Kanaujiya JK, Lochab S, Tripathi SB, Bhatt ML, Singh PK et al. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562. Proteomics 2011; 11: 1517-1529